Literature DB >> 7711729

Expression of the mutant allele of IT-15 (the HD gene) in striatum and cortex of Huntington's disease patients.

O C Stine1, S H Li, N Pleasant, M V Wagster, J C Hedreen, C A Ross.   

Abstract

Huntington's disease (HD) is an inherited neurodegenerative disorder expressed when a trinucleotide repeat in the gene IT-15 is expanded. The mechanism by which the expanded repeat causes the expression of the disease is unknown. Possible mechanisms include alterations in the amount of the mRNA, potentially resulting from changes in gene transcription or abnormal mRNA stability. In order to determine whether the expanded IT-15 allele is present in mRNA, we isolated total RNA from the cortex and striatum of patients and controls. To distinguish the two alleles of the IT-15 transcript in HD patients, we amplified across a region containing a dimorphic single triplet deletion observed on some chromosomes and found that the relative intensity of the two PCR bands amplified from genomic DNA and those amplified from first strand cDNA from brain tissue were essentially equal. In order to determine whether the exon containing the expanded CAG repeat is present in IT-15 mRNA from HD patients, we amplified across this region and demonstrated the presence of the expanded repeat in cDNA from both striatum and cortex. Based on this evidence, we suggest that the mechanism of disease expression does not occur during transcription or in the stability of the RNA, but rather occurs during translation or postranslationally.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7711729     DOI: 10.1093/hmg/4.1.15

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  8 in total

1.  Somatic mosaicism of expanded CAG repeats in brains of patients with dentatorubral-pallidoluysian atrophy: cellular population-dependent dynamics of mitotic instability.

Authors:  H Takano; O Onodera; H Takahashi; S Igarashi; M Yamada; M Oyake; T Ikeuchi; R Koide; H Tanaka; K Iwabuchi; S Tsuji
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

2.  A natural antisense transcript at the Huntington's disease repeat locus regulates HTT expression.

Authors:  Daniel W Chung; Dobrila D Rudnicki; Lan Yu; Russell L Margolis
Journal:  Hum Mol Genet       Date:  2011-06-13       Impact factor: 6.150

3.  Somatic mosaicism of the expanded CAG trinucleotide repeat in mRNAs for the responsible gene of Machado-Joseph disease (MJD), dentatorubral-pallidoluysian atrophy (DRPLA), and spinal and bulbar muscular atrophy (SBMA).

Authors:  Y Ito; F Tanaka; M Yamamoto; M Doyu; M Nagamatsu; S Riku; T Mitsuma; G Sobue
Journal:  Neurochem Res       Date:  1998-01       Impact factor: 3.996

4.  Analysis of the 5' upstream sequence of the Huntington's disease (HD) gene shows six new rare alleles which are unrelated to the age at onset of HD.

Authors:  R Coles; J Leggo; D C Rubinsztein
Journal:  J Med Genet       Date:  1997-05       Impact factor: 6.318

5.  CAG trinucleotide RNA repeats interact with RNA-binding proteins.

Authors:  B A McLaughlin; C Spencer; J Eberwine
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

6.  Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin.

Authors:  J Bao; A H Sharp; M V Wagster; M Becher; G Schilling; C A Ross; V L Dawson; T M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

7.  Making (anti-) sense out of huntingtin levels in Huntington disease.

Authors:  Melvin M Evers; Menno H Schut; Barry A Pepers; Melek Atalar; Martine J van Belzen; Richard Lm Faull; Raymund Ac Roos; Willeke M C van Roon-Mom
Journal:  Mol Neurodegener       Date:  2015-04-28       Impact factor: 14.195

8.  Transcription elongation and tissue-specific somatic CAG instability.

Authors:  Agathi-Vasiliki Goula; Agnieszka Stys; Jackson P K Chan; Yvon Trottier; Richard Festenstein; Karine Merienne
Journal:  PLoS Genet       Date:  2012-11-29       Impact factor: 5.917

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.